← Back
$UTHR All transactions

UNITED THERAPEUTICS Corp

▼ SELL 10b5-1 Plan

$ Value

$357K

Shares

720

Price

$496

Filed

Dec 16

Insider

Name

BENKOWITZ MICHAEL

Title

PRESIDENT AND COO

CIK

0001673232

Roles

Officer

Transaction Details

Transaction Date

2025-12-15

Code

S

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

3,272

Footnotes

This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025. | Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have shared investment and voting power. | This transaction was executed in multiple trades at prices ranging from $490.65 to $491.63. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $491.76 to $492.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $492.77 to $493.76. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $493.78 to $494.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $494.81 to $495.80. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $495.81 to $496.79. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $496.86 to $497.84. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $497.91 to $498.90. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $498.93 to $499.92. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $500.14 to $500.40. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person's family members are beneficiaries, and as to which the Reporting Person has sole investment and voting power. | This transaction was executed in multiple trades at prices ranging from $495.81 to $496.79. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Filing Info

Accession No.

0001673232-25-000016

Form Type

4

Issuer CIK

0001082554

BENKOWITZ MICHAEL's History

Date Ticker Type Value
2026-03-15 UTHR M
2026-03-15 UTHR M
2026-03-15 UTHR F $4.2M
2026-03-15 UTHR F $3.7M
2026-03-15 UTHR M $0
2026-03-15 UTHR M $0
2026-02-23 UTHR M $1.1M
2026-02-23 UTHR $4.4M
2026-02-23 UTHR M $740K
2026-02-23 UTHR $2.4M

Other Insiders at UTHR (90d)

Insider Bought Sold Last
ROTHBLATT MARTINE A
Chairperson & CEO
$193.8M 2026-04-22
KURZWEIL RAY $2.4M 2026-03-04
PATUSKY CHRISTOPHER $579K 2026-04-17
MAHON PAUL A
EVP & GENERAL COUNSEL
$25.9M 2026-04-16
CAUSEY CHRISTOPHER $1.3M 2026-03-30
Thompson Tommy G $2.1M 2026-03-26
Olian Judy D. $417K 2026-03-23
EDGEMOND JAMES
CFO AND TREASURER
$50.8M 2026-04-20
BENKOWITZ MICHAEL
PRESIDENT AND COO
$60.0M 2026-03-15
MALCOLM JAN $97K 2026-03-17